HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matteo Bassetti Selected Research

Soft Tissue Infections

1/2019Influence of age on the clinical efficacy of tigecycline in severely ill patients.
1/2019Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections.
5/2018The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts.
1/2018The role of dalbavancin in skin and soft tissue infections.
1/2017Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
7/2016Hot topics in the diagnosis and management of skin and soft-tissue infections.
4/2016New therapeutic options for skin and soft tissue infections.
9/2015Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.
7/2013Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
7/2013Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matteo Bassetti Research Topics

Disease

157Infections
09/2022 - 08/2003
54COVID-19
06/2022 - 01/2020
48Critical Illness (Critically Ill)
04/2022 - 09/2009
30Sepsis (Septicemia)
09/2022 - 11/2010
27Pneumonia (Pneumonitis)
02/2022 - 09/2010
17Intraabdominal Infections
09/2022 - 07/2013
16Communicable Diseases (Infectious Diseases)
04/2022 - 03/2005
16Septic Shock (Toxic Shock Syndrome)
10/2021 - 10/2012
15Soft Tissue Infections
01/2019 - 01/2008
14Ventilator-Associated Pneumonia
09/2022 - 08/2007
14Endocarditis
01/2022 - 07/2004
14Candidemia
12/2021 - 02/2006
12Urinary Tract Infections (Urinary Tract Infection)
09/2022 - 07/2014
11Bacteremia
03/2021 - 07/2007
11Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 08/2012
10Healthcare-Associated Pneumonia
01/2022 - 04/2009
8Invasive Candidiasis
08/2022 - 09/2009
8Bacterial Infections (Bacterial Infection)
04/2022 - 08/2013
7Candidiasis (Moniliasis)
08/2019 - 10/2006
7Aspergillosis
01/2019 - 07/2014
6Bacterial Pneumonia
01/2022 - 12/2018
6Human Influenza (Influenza)
12/2021 - 05/2014
6Cross Infection (Nosocomial Infection)
04/2015 - 09/2010
5Mycoses (Diseases, Fungus)
01/2022 - 06/2015
5Neoplasms (Cancer)
01/2021 - 06/2014
5Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 07/2007
5Invasive Fungal Infections
04/2018 - 11/2011
4Respiratory Insufficiency (Respiratory Failure)
01/2022 - 07/2003
4Fever (Fevers)
12/2021 - 12/2011
4Osteomyelitis
01/2021 - 11/2017
3Gram-Negative Bacterial Infections
09/2022 - 10/2015
3Pulmonary Aspergillosis
01/2022 - 10/2016
3Disease Progression
12/2021 - 01/2021
3Coinfection
06/2021 - 05/2014
3Nausea
01/2021 - 04/2009
3Pseudomonas Infections
01/2021 - 12/2018
3Inflammation (Inflammations)
11/2020 - 01/2019
3Drug-Related Side Effects and Adverse Reactions
09/2020 - 12/2019

Drug/Important Bio-Agent (IBA)

90Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 08/2003
36Carbapenems (Carbapenem Antibiotics)IBA
09/2022 - 07/2013
33Pharmaceutical PreparationsIBA
01/2022 - 12/2008
14tazobactam drug combination ceftolozaneIBA
01/2022 - 01/2015
13ceftazidime drug combination avibactamIBA
09/2022 - 01/2019
12Tigecycline (Tygacil)FDA Link
09/2022 - 09/2010
11Colistin (Coly-Mycin)FDA Link
01/2022 - 01/2013
11Linezolid (Zyvox)FDA Link
01/2020 - 08/2003
11Fluconazole (Zonal)FDA LinkGeneric
08/2019 - 07/2007
10LactamsIBA
09/2022 - 04/2014
10carbapenemaseIBA
11/2021 - 10/2012
8eravacyclineIBA
09/2022 - 11/2014
8Antiviral Agents (Antivirals)IBA
02/2022 - 10/2015
8DaptomycinFDA Link
01/2022 - 08/2003
8Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2017
8Meropenem (Merrem)FDA LinkGeneric
01/2021 - 01/2016
8VancomycinFDA LinkGeneric
01/2020 - 06/2005
7Cephalosporins (Cephalosporin Antibiotics)IBA
09/2022 - 08/2003
7ProcalcitoninIBA
01/2022 - 03/2016
7delafloxacinIBA
01/2022 - 03/2015
7Amphotericin B (Amphotericin)FDA LinkGeneric
09/2020 - 07/2007
7EchinocandinsIBA
03/2020 - 01/2010
6FluoroquinolonesIBA
09/2022 - 06/2014
6Polymyxins (Polymyxin)IBA
04/2022 - 12/2020
6CeftarolineFDA Link
12/2021 - 04/2016
6AzolesIBA
01/2021 - 02/2006
5AminoglycosidesIBA
09/2022 - 01/2013
5CefiderocolIBA
09/2022 - 01/2019
5FosfomycinFDA Link
09/2022 - 01/2014
5beta-Lactamases (beta-Lactamase)IBA
10/2018 - 08/2007
5LipidsIBA
06/2015 - 01/2010
4meropenem and vaborbactamIBA
03/2022 - 12/2018
4beta-LactamsIBA
01/2022 - 01/2013
4Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
01/2022 - 01/2016
4AztreonamFDA LinkGeneric
12/2021 - 01/2018
4dalbavancinIBA
01/2021 - 01/2018
4Neuraminidase (Sialidase)IBA
01/2020 - 05/2014
4Voriconazole (Vfend)FDA LinkGeneric
01/2020 - 07/2007
4GlycopeptidesIBA
05/2018 - 07/2004
4Methicillin (Metin)FDA Link
07/2013 - 06/2005
3Monoclonal AntibodiesIBA
06/2022 - 10/2021
3Caspofungin (Cancidas)FDA Link
12/2021 - 08/2004
3cefepime-zidebactamIBA
12/2021 - 11/2020
3Cefepime (Maxipime)FDA LinkGeneric
12/2021 - 11/2020
3C-Reactive ProteinIBA
01/2021 - 03/2016
3EnzymesIBA
12/2020 - 03/2011
3Amikacin (A.M.K)FDA LinkGeneric
09/2020 - 04/2018

Therapy/Procedure

103Therapeutics
09/2022 - 07/2003
22Critical Care (Surgical Intensive Care)
04/2022 - 02/2006
12Artificial Respiration (Mechanical Ventilation)
02/2022 - 04/2008
8Mechanical Ventilators (Ventilator)
01/2022 - 10/2017
8Duration of Therapy
10/2020 - 05/2016
7Drug Therapy (Chemotherapy)
02/2022 - 04/2005
7Liver Transplantation
08/2019 - 05/2014
5Transplantation
03/2020 - 05/2014
5Length of Stay
01/2020 - 04/2008
4Parenteral Nutrition
04/2022 - 07/2007
4Personal Protective Equipment
06/2021 - 10/2020
4Continuous Renal Replacement Therapy
05/2020 - 12/2018
4Hematopoietic Stem Cell Transplantation
12/2017 - 08/2015
4Central Venous Catheters
03/2015 - 07/2007
3Noninvasive Ventilation
12/2021 - 03/2014